Literature DB >> 11422925

Herbs and supplements in dialysis patients: panacea or poison?

N V Dahl1.   

Abstract

The safety of herbal remedies and supplement use is of particular concern in patients with renal disease, and reliable information is not always easy to find. Predialysis patients may be drawn to complementary and alternative medicine (CAM) because they believe it can help prevent the progression of their renal disease. The purpose of this series of articles on alternative medicine for nephrologists is to address concerns and issues specific to CAM use in dialysis patients and to provide a guide to reliable sources of information. This introductory article emphasizes safety issues with a focus primarily on herbal medicine. Lack of regulation means that patients may not actually be taking what they think they are. Independent laboratory analyses have shown a lack of stated label ingredients and many instances of supplements and traditional remedies being contaminated with pesticides, poisonous plants, heavy metals, or conventional drugs. While certain supplements are always unsafe (carcinogenic, hepatotoxic, glandular extracts), others are specifically contraindicated in renal disease. Supplement use may be especially hazardous in renal disease because of unpredictable pharmacokinetics, drug interactions, negative effects on kidney function, nephrotoxicity, hemodynamic alterations, unpredictable effects on blood pressure or blood glucose, or potentiation of electrolyte abnormalities. There are no data on potential dialyzability of either active compounds, or their potentially active or toxic metabolites. Many supplements contain metal ions and other minerals. Transplant recipients are also at risk from potential unpredictable effects on immune function. Recommendations and information resources are listed.

Entities:  

Mesh:

Year:  2001        PMID: 11422925     DOI: 10.1046/j.1525-139x.2001.00051.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  9 in total

1.  Herbal Supplement Use and Herb-drug Interactions among Patients with Kidney Disease.

Authors:  Soroush Mohammadi; Gholamreza Asghari; Afsoon Emami-Naini; Marjan Mansourian; Shirinsadat Badri
Journal:  J Res Pharm Pract       Date:  2020-06-26

2.  Traditional and complementary medicine use among chronic haemodialysis patients: a nationwide cross-sectional study.

Authors:  Nor Fadhlina Zakaria; Mohd Tawfeq Mohd Noor; Rafidah Abdullah
Journal:  BMC Complement Med Ther       Date:  2021-03-16

3.  Use of complementary and alternative medicines in haemodialysis patients: a cross-sectional study from Palestine.

Authors:  Sa'ed H Zyoud; Samah W Al-Jabi; Waleed M Sweileh; Ghada H Tabeeb; Nora A Ayaseh; Mayas N Sawafta; Razan L Khdeir; Diana O Mezyed; Dala N Daraghmeh; Rahmat Awang
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

4.  Assessing the efficacy and safety of Juan Bi Tang for dialysis-related myofascial pain in the fistula arm: Study protocol for a randomized cross-over trial.

Authors:  Yung-Tang Hsu; Hwee-Yeong Ng; Yung-Hsiang Chen; Yu-Chuen Huang; Yan-Yuh Lee; Ming-Yen Tsai
Journal:  Front Public Health       Date:  2022-08-19

5.  Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis.

Authors:  Aravapalli S M Arjuna Rao; D Phaneendra; Ch Divya Pavani; P Soundararajan; N Vanitha Rani; P Thennarasu; G Kannan
Journal:  J Pharm Bioallied Sci       Date:  2016 Jan-Mar

6.  Complementary and Alternative Medicine Practice Among Saudi Patients with Chronic Kidney Disease: A Cross-Sectional Study.

Authors:  Layla AlAnizy; Khalid AlMatham; Asmaa Al Basheer; Isamme AlFayyad
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-01-29

7.  Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study.

Authors:  Fei Yee Lee; Farida Islahudin; Mohd Makmor-Bakry; Hin-Seng Wong; Sunita Bavanandan
Journal:  Int J Clin Pharm       Date:  2021-03-06

8.  Creation of a Natural Health Products Database for Assessing Safety for Patients with Chronic Kidney Disease or Renal Transplant.

Authors:  Sharon Leung; Karen Shalansky; Puneet Vashisht; Marianna Leung; Judith G Marin
Journal:  Can J Hosp Pharm       Date:  2017-10-31

9.  Polypharmacy and mortality association by chronic kidney disease status: The REasons for Geographic And Racial Differences in Stroke Study.

Authors:  Winn Cashion; William McClellan; Suzanne Judd; Abhinav Goyal; David Kleinbaum; Michael Goodman; Valerie Prince; Paul Muntner; George Howard
Journal:  Pharmacol Res Perspect       Date:  2021-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.